16-23348878-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000336.3(SCNN1B):​c.279T>C​(p.Pro93Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.592 in 1,613,704 control chromosomes in the GnomAD database, including 294,935 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.67 ( 36163 hom., cov: 30)
Exomes 𝑓: 0.58 ( 258772 hom. )

Consequence

SCNN1B
NM_000336.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: -3.32

Publications

27 publications found
Variant links:
Genes affected
SCNN1B (HGNC:10600): (sodium channel epithelial 1 subunit beta) Nonvoltage-gated, amiloride-sensitive, sodium channels control fluid and electrolyte transport across epithelia in many organs. These channels are heteromeric complexes consisting of 3 subunits: alpha, beta, and gamma. This gene encodes the beta subunit, and mutations in this gene have been associated with pseudohypoaldosteronism type 1 (PHA1), and Liddle syndrome. [provided by RefSeq, Apr 2009]
SCNN1B Gene-Disease associations (from GenCC):
  • Liddle syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • pseudohypoaldosteronism, type IB2, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics
  • bronchiectasis with or without elevated sweat chloride 1
    Inheritance: AD, SD Classification: STRONG, LIMITED Submitted by: PanelApp Australia, Ambry Genetics
  • pseudohypoaldosteronism, type IB1, autosomal recessive
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • Liddle syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 16-23348878-T-C is Benign according to our data. Variant chr16-23348878-T-C is described in ClinVar as Benign. ClinVar VariationId is 165167.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.32 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.962 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCNN1BNM_000336.3 linkc.279T>C p.Pro93Pro synonymous_variant Exon 2 of 13 ENST00000343070.7 NP_000327.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCNN1BENST00000343070.7 linkc.279T>C p.Pro93Pro synonymous_variant Exon 2 of 13 1 NM_000336.3 ENSP00000345751.2

Frequencies

GnomAD3 genomes
AF:
0.666
AC:
101178
AN:
151872
Hom.:
36106
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.905
Gnomad AMI
AF:
0.704
Gnomad AMR
AF:
0.503
Gnomad ASJ
AF:
0.573
Gnomad EAS
AF:
0.985
Gnomad SAS
AF:
0.814
Gnomad FIN
AF:
0.512
Gnomad MID
AF:
0.699
Gnomad NFE
AF:
0.552
Gnomad OTH
AF:
0.636
GnomAD2 exomes
AF:
0.621
AC:
155174
AN:
249886
AF XY:
0.629
show subpopulations
Gnomad AFR exome
AF:
0.914
Gnomad AMR exome
AF:
0.435
Gnomad ASJ exome
AF:
0.582
Gnomad EAS exome
AF:
0.984
Gnomad FIN exome
AF:
0.501
Gnomad NFE exome
AF:
0.558
Gnomad OTH exome
AF:
0.600
GnomAD4 exome
AF:
0.584
AC:
853991
AN:
1461714
Hom.:
258772
Cov.:
60
AF XY:
0.590
AC XY:
428734
AN XY:
727148
show subpopulations
African (AFR)
AF:
0.918
AC:
30730
AN:
33480
American (AMR)
AF:
0.441
AC:
19733
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.578
AC:
15113
AN:
26136
East Asian (EAS)
AF:
0.988
AC:
39241
AN:
39700
South Asian (SAS)
AF:
0.785
AC:
67697
AN:
86256
European-Finnish (FIN)
AF:
0.501
AC:
26748
AN:
53414
Middle Eastern (MID)
AF:
0.716
AC:
4130
AN:
5768
European-Non Finnish (NFE)
AF:
0.552
AC:
613593
AN:
1111854
Other (OTH)
AF:
0.613
AC:
37006
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
19478
38956
58434
77912
97390
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17440
34880
52320
69760
87200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.666
AC:
101278
AN:
151990
Hom.:
36163
Cov.:
30
AF XY:
0.668
AC XY:
49640
AN XY:
74282
show subpopulations
African (AFR)
AF:
0.905
AC:
37535
AN:
41464
American (AMR)
AF:
0.502
AC:
7662
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.573
AC:
1990
AN:
3472
East Asian (EAS)
AF:
0.985
AC:
5069
AN:
5146
South Asian (SAS)
AF:
0.814
AC:
3914
AN:
4808
European-Finnish (FIN)
AF:
0.512
AC:
5401
AN:
10558
Middle Eastern (MID)
AF:
0.707
AC:
208
AN:
294
European-Non Finnish (NFE)
AF:
0.552
AC:
37508
AN:
67956
Other (OTH)
AF:
0.639
AC:
1349
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1483
2967
4450
5934
7417
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
790
1580
2370
3160
3950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.598
Hom.:
60270
Bravo
AF:
0.674
Asia WGS
AF:
0.896
AC:
3114
AN:
3478
EpiCase
AF:
0.568
EpiControl
AF:
0.581

ClinVar

Significance: Benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Pro93Pro in exon 2 of SCNN1B: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 45.2% (3883/8600) of European American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs238547).

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Oct 21, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 24, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Pseudohypoaldosteronism, type IB1, autosomal recessive Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Liddle syndrome 1 Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Bronchiectasis with or without elevated sweat chloride 1 Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.28
DANN
Benign
0.58
PhyloP100
-3.3
PromoterAI
-0.022
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs238547; hg19: chr16-23360199; COSMIC: COSV108137889; API